Literature DB >> 32454741

Intrinsic Stability Study and Forced Degradation Profiling of Olopatadine Hydrochloride by RP-HPLC-DAD-HRMS Method.

Pawan Kumar Basniwal1,2, Deepti Jain1.   

Abstract

OBJECTIVES: Forced degradation determines the intrinsic stability of a molecule by establishing degradation pathways in order to identify the likely degradation products (DPs). The objective of the present research was to establish intrinsic stability and forced degradation profiling of olopatadine hydrochloride.
MATERIALS AND METHODS: The intrinsic stability of olopatadine hydrochloride was evaluated by RP-HPLC, where a mixture of 0.1% formic acid and organic phase (methanol:acetonitrile; 50:50 % v/v) was used as mobile phase at 1.0 mL/min in gradient mode. Different stress conditions were employed to explore the intrinsic stability of olopatadine hydrochloride.
RESULTS: In acidic condition, five DPs, i.e. OLO1, OLO2, OLO3, OLO4, and OLO5, were observed. OLO5 was the major DP that increased with time and the peak area of OLO was decreased. In addition to OLO3 and OLO5, two more DPs were observed in alkaline condition, i.e. OLO6 and OLO7. OLO5 and OLO6 were two major DPs; OLO5 increased with time while OLO6 had a zigzag pattern of peak area with time. All DPs of neutral condition were also found in acidic condition while OLO3 and OLO5 were common in all three types of hydrolytic degradation.
CONCLUSION: Thus, OLO has similar pattern of degradation profiling in all hydrolytic conditions (acidic, alkaline, and neutral). No degradation was found in thermal, ultraviolet light, or oxidative conditions over 10 days. OLO-Imp was recognized as an analogue structure of OLO and proposed as 11-[(3-dimethylamino)-propylidene]-6,11-dihydro-dibenz[b,e]oxepin-2-propanoic acid in standard drug. OLO1 was identified as (2-(4-(dimethylamino) butyl) phenyl)methanol, which may be formed by cleavage of the tricyclic ring in neutral condition. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  HPLC; Olopatadine hydrochloride; forced degradation

Year:  2019        PMID: 32454741      PMCID: PMC7227878          DOI: 10.4274/tjps.galenos.2018.83007

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  11 in total

Review 1.  A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.

Authors:  Saranjit Singh; Tarun Handa; Mallikarjun Narayanam; Archana Sahu; Mahendra Junwal; Ravi P Shah
Journal:  J Pharm Biomed Anal       Date:  2012-03-30       Impact factor: 3.935

Review 2.  Forced degradation and impurity profiling: recent trends in analytical perspectives.

Authors:  Deepti Jain; Pawan Kumar Basniwal
Journal:  J Pharm Biomed Anal       Date:  2013-07-31       Impact factor: 3.935

3.  A rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of olopatadine concentration in human plasma.

Authors:  Ping Zhu; Yu-Guan Wen; Xiao-Ping Fan; Zhi-Ling Zhou; Rui-Xin Fan; Ji-Mei Chen; Ke-Li Huang; Xiao-Lan Zhu; Yan-Fang Chen; Jian Zhuang
Journal:  J Anal Toxicol       Date:  2011-03       Impact factor: 3.367

4.  A Validated Capillary Electrophoretic Method for the Determination of Olopatadine and Its Application to a Pharmaceutical Preparation of Eye Drops.

Authors:  Tufan Güray; Tugba Turan; Muzaffer Tunçel; Ulku Dilek Uysal
Journal:  J AOAC Int       Date:  2017-01-01       Impact factor: 1.913

5.  Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities.

Authors:  Jiro Kajita; Keiko Inano; Eiichi Fuse; Takashi Kuwabara; Hiroyuki Kobayashi
Journal:  Drug Metab Dispos       Date:  2002-12       Impact factor: 3.922

6.  Determination of olopatadine, a new antiallergic agent, and its metabolites in human plasma by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry.

Authors:  K Fujita; H Magara; H Kobayashi
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-08-20

7.  Stability-indicating high-performance column liquid chromatography and high-performance thin-layer chromatography methods for the determination of olopatadine hydrochloride in tablet dosage form.

Authors:  Susheel John Varghese; A Manikanta Kumar; Thengungal Kochupappy Ravi
Journal:  J AOAC Int       Date:  2011 Nov-Dec       Impact factor: 1.913

8.  Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives.

Authors:  E Ohshima; S Otaki; H Sato; T Kumazawa; H Obase; A Ishii; H Ishii; K Ohmori; N Hirayama
Journal:  J Med Chem       Date:  1992-05-29       Impact factor: 7.446

9.  Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis.

Authors:  Stephen V Scoper; Gregg J Berdy; Steven J Lichtenstein; Jay M Rubin; Marc Bloomenstein; Robert E Prouty; Cullen T Vogelson; Michael R Edwards; Curtis Waycaster; Terri Pasquine; Robert D Gross; Stella M Robertson
Journal:  Adv Ther       Date:  2007 Nov-Dec       Impact factor: 3.845

10.  Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.

Authors:  Hitoshi Takahashi; Yan Zhang; Eishin Morita
Journal:  Arch Dermatol Res       Date:  2008-02-28       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.